Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor–negative juvenile idiopathic arthritis in Finnish patients: Haplotype analysis in Finnish families

• Published in: Arthritis and rheumatism 2005-01, Vol.52 (1), p.247-256
• Main Authors: Runstadler, Jonathan A., Säilä, Hanna, Savolainen, Anneli, Leirisalo‐Repo, Marjatta, Aho, Kimmo, Tuomilehto‐Wolf, Eva, Tuomilehto, Jaakko, Seldin, Michael F.
• Format: Article
• Language: English
• Subjects: Adolescent; Aged; Arthritis, Juvenile - blood; Arthritis, Juvenile - genetics; Arthritis, Juvenile - immunology; Biological and medical sciences; Case-Control Studies; Cation Transport Proteins - genetics; Child; Child, Preschool; Chromosomes, Human, Pair 2; Diseases of the osteoarticular system; Epitopes; Female; Finland; Genetic Markers; Genetic Predisposition to Disease; Haplotypes; HLA-DR Antigens - genetics; HLA-DR Antigens - immunology; HLA-DRB1 Chains; Humans; Infant; Infant, Newborn; Inflammatory joint diseases; Male; Medical sciences; Rheumatoid Factor - blood
• ISSN: 0004-3591; 1529-0131
• DOI: 10.1002/art.20772

Objective The SLC11A1 (formerly called NRAMP1) gene is important in natural resistance to a variety of intracellular infections mediated by macrophages and has been proposed as a candidate gene for autoimmune disease susceptibility. The aim of this study was to examine susceptibility in Finnish patients with persistent oligoarticular and polyarticular rheumatoid factor (RF)–negative juvenile idiopathic arthritis (JIA) due to the presence of the SLC11A1 locus on chromosome 2. Methods A total of 234 Finnish JIA nuclear families and 639 elderly Finnish controls without a history of JIA were evaluated for association with JIA at 3 intragenic single‐nucleotide polymorphisms: an intragenic insertion/deletion, a promoter microsatellite (NRAMP1), and a 3′ microsatellite (D2S1471). Results Analysis of marker haplotypes demonstrated a strong association of Finnish JIA with 6‐marker, 4‐marker, and 2‐marker haplotypes. Most impressively, 1 of the 6‐marker haplotypes showed an odds ratio (OR) of 4.0 (95% confidence interval [95% CI] 2.6–6.2) in all JIA patients, 3.5 (95% CI 1.9–6.5) in those with persistent oligoarticular JIA, and 4.1 (95% CI 2.5–6.7) in those with polyarticular RF‐negative JIA. Stratification of the haplotype data suggested that susceptibility to JIA in the haplotype spanning the SLC11A1 locus is independent (P < 0.01) of an association with a DRB1 JIA shared epitope (DRB1*JIASE) that includes well‐characterized strong susceptibility to DRB1*08 and *11 alleles. This SLC11A1 haplotype also had an additive effect with DRB1*JIASE in those with polyarticular, but not those with persistent oligoarticular, disease (P = 0.06, OR 2.9 [95% CI 0.9–9.2] versus P = 0.5, OR 1.6 [95% CI 0.4–6.0]). Conclusion Taken together, these data provide support for the existence of a locus at or near SLC11A1 that is a strong susceptibility factor for JIA in Finnish patients.